LncRNA miR663AHG represses the development of colon cancer in a miR663a-dependent manner

[1]  D. Deng,et al.  TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern , 2022, Oncogene.

[2]  Ningjing Song,et al.  Long non-coding RNA RP11-342L8.2, derived from RNA sequencing and validated via RT-qPCR, is upregulated and correlates with disease severity in psoriasis patients , 2022, Irish Journal of Medical Science (1971 -).

[3]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[4]  L. Luo,et al.  SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback. , 2021, Cancer letters.

[5]  Rui Wang,et al.  Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression , 2021, Cell Death & Disease.

[6]  Yixuan Hou,et al.  A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties , 2021, Journal of Hematology & Oncology.

[7]  G. Hu,et al.  Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63 , 2021, Nature Communications.

[8]  Juze Yang,et al.  LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC , 2021, Journal of Hematology & Oncology.

[9]  Yanyong Yang,et al.  Long non-coding RNA ANRIL promotes homologous recombination-mediated DNA repair by maintaining ATR protein stability to enhance cancer resistance , 2021, Molecular Cancer.

[10]  J. Saiz,et al.  Right‐sided non‐recurrent laryngeal nerve without any vascular anomaly: an anatomical trap , 2021, ANZ journal of surgery.

[11]  Ming Li,et al.  Prediction of a Potential Mechanism of Intervertebral Disc Degeneration Based on a Novel Competitive Endogenous RNA Network , 2021, BioMed research international.

[12]  Xian Shen,et al.  Long noncoding RNAs: functions and mechanisms in colon cancer , 2020, Molecular Cancer.

[13]  Aimin Li,et al.  CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling , 2020, Journal of Experimental & Clinical Cancer Research.

[14]  X. Shang,et al.  Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets , 2020, PeerJ.

[15]  Aimin Li,et al.  CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling , 2020, Journal of experimental & clinical cancer research : CR.

[16]  D. Deng,et al.  Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells , 2020, Molecular Cancer.

[17]  M. Dianatpour,et al.  CRISPR/Cas9-mediated knockout of MLL5 enhances apoptotic effect of cisplatin in HeLa cells in vitro , 2020, EXCLI journal.

[18]  Christopher D. Brown,et al.  The GTEx Consortium atlas of genetic regulatory effects across human tissues , 2019, Science.

[19]  Zemin Zhang,et al.  GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..

[20]  Senlin Zhao,et al.  MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility , 2019, EBioMedicine.

[21]  D. Deng,et al.  miR663a-TTC22V1 axis inhibits colon cancer metastasis , 2019, Oncology reports.

[22]  Guoqing Zhang,et al.  miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma , 2018, BMC Cancer.

[23]  D. Deng,et al.  MALAT1–miR663a negative feedback loop in colon cancer cell functions through direct miRNA–lncRNA binding , 2018, Cell Death & Disease.

[24]  E. Tili,et al.  MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol , 2018, Medicines.

[25]  T. Yeatman,et al.  lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling , 2017, Nature Medicine.

[26]  P. Nangia-Makker,et al.  A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells , 2017, Molecular Cancer.

[27]  Ming Sun,et al.  Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer , 2017, Molecular Cancer.

[28]  M. Krstic-Demonacos,et al.  miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway , 2017, BMC Cancer.

[29]  J. Beermann,et al.  Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. , 2016, Physiological reviews.

[30]  T. Gabaldón,et al.  Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer , 2016, Front. Genet..

[31]  You-hong Cui,et al.  miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma , 2015, Clinical Cancer Research.

[32]  Runsheng Chen,et al.  The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. , 2015, Cell stem cell.

[33]  Shenghao Xu,et al.  Supplementary Information , 2014, States at War, Volume 3.

[34]  Yongwei Yu,et al.  miR‐663 Induces Castration‐Resistant Prostate Cancer Transformation and Predicts Clinical Recurrence , 2014, Journal of cellular physiology.

[35]  Pavel Vodicka,et al.  HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. , 2014, Carcinogenesis.

[36]  Jian Lu,et al.  Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. , 2013, The Lancet. Oncology.

[37]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[38]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[39]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[40]  J. Yun,et al.  MiR-663, a microRNA targeting p21WAF1/CIP1, promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma , 2012, Oncogene.

[41]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[42]  C. Croce,et al.  Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. , 2010, Biochemical pharmacology.

[43]  C. Croce,et al.  Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. , 2010, Carcinogenesis.

[44]  B. Cullen,et al.  The imprinted H19 noncoding RNA is a primary microRNA precursor. , 2007, RNA.

[45]  Qian Liu,et al.  A high-throughput method to monitor the expression of microRNA precursors. , 2004, Nucleic acids research.

[46]  Jacob D. Jaffe,et al.  Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.

[47]  X. Li,et al.  Transcriptional regulation of mammalian miRNA genes. , 2011, Genomics.